The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc poole...
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Schizophrenia is a chronic and debilitating neuropsychiatric disorder that often requires long-term pharmacotherapy to manage symptoms and prevent relapse. Cariprazine is a potent dopamine D
and D
receptor partial agonist that is FDA-approved in the US for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I di...
Alternative Titles
Full title
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c4e1476cce9d4bc396cf63f0a7667304
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c4e1476cce9d4bc396cf63f0a7667304
Other Identifiers
ISSN
1471-244X
E-ISSN
1471-244X
DOI
10.1186/s12888-017-1459-z
